ICD-10-CM Billable Code

D3A.012

Benign carcinoid tumor of the ileum

Clinical Classification Guidelines

Medical Intelligence & Overview

A benign carcinoid tumor of the ileum refers to a non-cancerous growth that develops in the ileum, which is the last part of the small intestine. Although benign, these tumors can grow slowly over time and may sometimes cause symptoms or complications. Recognizing and understanding this condition is essential for appropriate management and monitoring. This article provides an overview of the causes, symptoms, diagnosis, and treatment options for benign carcinoid tumors of the ileum.

Causes & Symptoms

Clinical Causes: The exact cause of benign carcinoid tumors of the ileum remains unclear. However, some factors that may contribute include: - Genetic mutations leading to abnormal cell growth - Certain inherited syndromes like Multiple Endocrine Neoplasia type 1 (MEN1) - Family history of gastrointestinal tumors - Chronic inflammation of the intestines - Exposure to environmental carcinogens (though less common) While these factors may increase the risk, most cases occur sporadically without a clear cause.

Key Symptoms: Since benign carcinoid tumors of the ileum can be small and asymptomatic, many individuals may not experience noticeable symptoms. When symptoms occur, they may include: - Abdominal pain or cramping - Feeling of fullness or bloating - Intermittent diarrhea - Unexplained weight loss - Nausea or vomiting In some cases, the tumor may produce hormones that lead to specific syndromes, causing symptoms such as flushing or wheezing, though these are more common with functional carcinoid tumors. If the tumor grows or spreads, it could cause complications like intestinal blockage or bleeding.

Diagnostic & Treatment

Diagnosis Path: Diagnosing a benign carcinoid tumor of the ileum typically involves several steps: - Medical history review and physical examination - Imaging tests such as CT scan, MRI, or somatostatin receptor scintigraphy (Octreoscan) to locate tumors - Endoscopy or capsule endoscopy to visualize the small intestine - Biopsy during endoscopy or surgery to examine tissue samples - Laboratory tests measuring hormone levels or tumor markers, if hormone activity is suspected These diagnostic tools assist healthcare providers in confirming the presence of the tumor and assessing its size and location.

Treatment Protocols: Management of benign carcinoid tumors of the ileum often involves: - Surgical removal of the tumor, especially if it is causing symptoms or has grown significantly - Regular monitoring with imaging and clinical evaluations if the tumor is small and asymptomatic - In cases where the tumor produces hormones, medications that block hormone effects or inhibit tumor activity may be used - Addressing any complications such as intestinal blockage or bleeding promptly The prognosis is generally excellent for benign tumors following appropriate treatment, with low chances of recurrence or malignancy. However, ongoing follow-up is important to monitor for potential changes.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D3A.012 a billable ICD-10 code?
Yes, D3A.012 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D3A.012?
Clinical documentation must specify the nature of Benign carcinoid tumor of the ileum and any associated comorbidities for accurate reporting.

Cite this Clinical Reference